Disphar International B.V.
3 clinical trials · Sponsor
◉ Watch Disphar International B.V.
| Record | Firm | Date |
|---|---|---|
| Bioequivalence Study of Gliclazide 120 mg Modified Release Tablets (NCT02980757) | Disphar International B.V. | 2014-06-01 |
| Study of Teysuno (S-1) Combined With Epirubicin and Oxaliplatin in Patients With Advanced Solid Tumors (NCT02867397) | Disphar International B.V. | 2012-01-01 |
| Comparative Bioavailability Study of Metformin HCl 1000 mg Granules vs Glucophage 1000 mg Film-coated Tablet (NCT02217670) | Disphar International B.V. |
Track Disphar International B.V. automatically
Every clearance here is in the API, with alerts when new ones post.